NICOLE CLARK: Open Payments
NPI 1689395311 · MANTUA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 48 payments from 14 companies in 2025. Trend: 2023 $65 · 2024 $441 · 2025 $680
Food & beverage: $664Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $169 |
| Regeneron Healthcare Solutions, Inc. | 12 | $165 |
| Lilly USA, LLC | 3 | $49 |
| GENZYME CORPORATION | 2 | $44 |
| Galderma Laboratories, L.P. | 3 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Organon LLC | 2 | $32 |
| Kerecis Limited | 1 | $31 |
| LEO Pharma Inc. | 1 | $18 |
Products named: DUPIXENT, SKYRIZI, TALTZ, NEMLUVIO, Otezla, Kerecis SurgiClose, LIBTAYO, Rhapsido.
Industry payments across NJ — which companies pay providers there.
